vitiligo
Conditions
Interventions
control group:Placebo for the first three months (1 dose every other day), Qufengrouganxiaobaifang for the next three months (2 doses per week)
intervention group:Qufengrouganxiaobaifang,One dose every other day in the first three months, and two doses every week in the next three months
Sponsors
Chongqing Hospital of traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.non-segmental vitiligo in the progressive period 2.TCM syndrome differentiation is wind pathogen with blood stasis syndrome 3.1%<skin lesion area <50% 4.18=age=60 5.no systematic treatment in recent 3 months, no physical therapy in recent 1 month 6.no other skin diseases need to be treated, and no other serious diseases of important organs
Exclusion criteria
Exclusion criteria: 1.patients with difficulty in follow-up 2.acral vitiligo 3.pregnant and lactating patients 4.refuse to sign informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the change of white area; | — |
Secondary
| Measure | Time frame |
|---|---|
| DLQI;the adverse event;the change of white spot color;circulating biomarker; | — |
Countries
China
Contacts
Public ContactWang Yuyi
Outcome results
None listed